✦ LIBER ✦

Influence of Age/Gender/Race on the Efficacy of Ezetimibe/Simvastatin vs. Atorvastatin in Metabolic Syndrome Patients with Moderately High/High CHD Risk

✍ Scribed by Jennifer Robinson; Christie M. Ballantyne; Scott M. Grundy; Willa A. Hsueh; Hans-Henrik Parving; Jeffrey B. Rosen; Jianxin Lin; Robert S. Lowe; Arvind K. Shah; Andrew M. Tershakovec

Book ID: 119287733
Publisher: Elsevier
Year: 2009
Tongue: English
Weight: 297 KB
Volume: 3
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2009.04.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Do Age, Gender, and Race Affect the Effi

Do Age, Gender, and Race Affect the Efficacy of Ezetimibe Plus Atorvastatin vs. Doubling the Atorvastatin Dose in Moderately High and High CHD Risk Patients?

✍ Harold Edward Bays; Scott Conard; Lawrence A. Leiter; Steve Bird; Robert S. Lowe 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 233 KB

Effect of Metabolic Syndrome Factors and

Effect of Metabolic Syndrome Factors and Insulin Resistance on Ezetimibe/Simvastatin and Atorvastatin Treatment Efficacy in Patients with Metabolic Syndrome and Moderately High/High CHD Risk

✍ Jeffrey B. Rosen; Christie M. Ballantyne; Scott M. Grundy; Willa A. Hsueh; Hans- 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 264 KB

Influence of age, gender, and race on th

Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart disease

✍ Harold E. Bays; Scott E. Conard; Lawrence A. Leiter; Steven R. Bird; Robert S. L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Safety and Efficacy of Ezetimibe/Simvast

Safety and Efficacy of Ezetimibe/Simvastatin Combination Versus Atorvastatin Alone in Adults ≥65 Years of Age With Hypercholesterolemia and With or at Moderately High/High Risk for Coronary Heart Disease (the VYTELD Study)

✍ JoAnne M. Foody; W. Virgil Brown; Franklin Zieve; Adeniyi J. Adewale; Doreen Fla 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 954 KB

Does Baseline Body Mass Index, Fasting B

Does Baseline Body Mass Index, Fasting Blood Sugar, and High-Sensitivity C-Reactive Protein Influence the Efficacy of Adding Ezetimibe to Atorvastatin Versus Doubling the Atorvastatin Dose in Moderately High and High Coronary Heart Disease Risk Patients?

✍ Harold Edward Bays; Scott Conard; Lawrence A. Leiter; Steven Bird; Arvind K. Sha 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 268 KB

Achievement of specified low-density lip

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

✍ Jennifer G. Robinson; Christie M. Ballantyne; Willa Hsueh; Jeffrey Rosen; Jianxi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 469 KB